the upside from isis pharma could be good. been recommending it for two and a half years because of technology that allows them to change rna in your cells to fix problems caused by genetic abnormalities giving them one of the best pipelines in business. last time we spoke was inner may. we learneded the company had licensed its anticoagulant drug which stops blood clots from forming without causing excess bleeding. since then the stock rallied 14%. today we got terrific data on one of the pipeline drugs i love so much. a treatment for spinal muscular atrophy which is the leading cause of infantile death worldwide. these phase two results show the compound is saving babies lives and increasing muscle nungs. this is one of many impressive prospects. isis has a drug in phase three for a rare and often fatal genetic disease along with a phase two treatment for high triglyceride levels diabetes at an early stage cancer treatment. now let's check in with dr. stanley crooke of isis pharmaceuticals to hear about the data and where th